Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.5250 (11.44%) ($8.5250 - $8.5650) on Tue. Nov. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.58% (three month average) | RSI | 70 | Latest Price | $8.5250(11.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.2% a day on average for past five trading days. | Weekly Trend | EDIT advances 10.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(82%) XBI(80%) ARKK(76%) IVW(75%) IBUY(69%) | Factors Impacting EDIT price | EDIT will decline at least -2.29% in a week (0% probabilities). EDOC(-34%) TBT(-28%) UUP(-8%) VXX(-5%) BNDX(1%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.29% (StdDev 4.58%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.02(6.3%) | 10 Day Moving Average | $7.99(6.7%) | 20 Day Moving Average | $7.26(17.42%) | To recent high | -6.6% | To recent low | 36.2% | Market Cap | $529m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |